Goilav C - Search Results

1

Risk factors for infection with human immmunodeficiency virus among European expatriates in Africa.

Bonneux L, Van der Stuyft P, Taelman H, Cornet P, Goilav C, van der Groen G, Piot P. Bonneux L, et al. Among authors: goilav c. BMJ. 1988 Sep 3;297(6648):581-4. doi: 10.1136/bmj.297.6648.581. BMJ. 1988. PMID: 3139219 Free PMC article.

2

Protective efficacy of a recombinant DNA vaccine against hepatitis B in male homosexuals: results at 36 months.

Goilav C, Prinsen H, Piot P. Goilav C, et al. Vaccine. 1990 Mar;8 Suppl:S50-2; discussion S60-2. doi: 10.1016/0264-410x(90)90219-c. Vaccine. 1990. PMID: 2139284 Clinical Trial.

3

Hepatitis B: transmission by sexual contact and needle sharing.

Piot P, Goilav C, Kegels E. Piot P, et al. Among authors: goilav c. Vaccine. 1990 Mar;8 Suppl:S37-40; discussion S41-3. doi: 10.1016/0264-410x(90)90215-8. Vaccine. 1990. PMID: 2183516 Review.

4

Vaccination against hepatitis B in homosexual men. A review.

Goilav C, Piot P. Goilav C, et al. Am J Med. 1989 Sep 4;87(3A):21S-25S. doi: 10.1016/0002-9343(89)90526-3. Am J Med. 1989. PMID: 2528293 Review.

5

Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection.

Vanham G, Kestens L, Penne G, Goilav C, Gigase P, Colebunders R, Vandenbruaene M, Goeman J, van der Groen G, Ceuppens JL. Vanham G, et al. Among authors: goilav c. J Clin Immunol. 1991 Nov;11(6):345-56. doi: 10.1007/BF00918800. J Clin Immunol. 1991. PMID: 1761640

6

Immunogenicity and tolerance of a yeast-derived hepatitis B vaccine in homosexual men.

Prinsen H, Goilav C, Safary A, André FE, Piot P. Prinsen H, et al. Among authors: goilav c. Postgrad Med J. 1987;63 Suppl 2:147-9. Postgrad Med J. 1987. PMID: 3317352 Clinical Trial.

7

Non-response to a recombinant pre-S2-containing hepatitis B vaccine: association with the HLA-system.

Vingerhoets J, Goilav C, Vanham G, Kestens L, Muylle L, Kegels E, Van Hoof J, Piot P, Gigase P. Vingerhoets J, et al. Among authors: goilav c. Ann Soc Belg Med Trop. 1995 Jun;75(2):125-9. Ann Soc Belg Med Trop. 1995. PMID: 7487199

8

Immunological parameters during treatment with ditiocarb (Imuthiol).

Vanham GL, Kestens L, Van Hoof J, Penne G, Colebunders R, Goilav C, Vandenbruaene M, el Habib R, Gigase P. Vanham GL, et al. Among authors: goilav c. AIDS. 1993 Apr;7(4):525-30. doi: 10.1097/00002030-199304000-00012. AIDS. 1993. PMID: 8389559 Clinical Trial.

9

Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study.

Goilav C, Zuckerman J, Lafrenz M, Vidor E, Lauwers S, Ratheau C, Benichou G, Zuckerman A. Goilav C, et al. J Med Virol. 1995 Jul;46(3):287-92. doi: 10.1002/jmv.1890460321. J Med Virol. 1995. PMID: 7561805 Clinical Trial.

10

Prevalence of hepatitis A, B and C in the Flemish population.

Beutels M, Van Damme P, Aelvoet W, Desmyter J, Dondeyne F, Goilav C, Mak R, Muylle L, Pierard D, Stroobant A, Van Loock F, Waumans P, Vranckx R. Beutels M, et al. Among authors: goilav c. Eur J Epidemiol. 1997 Apr;13(3):275-80. doi: 10.1023/a:1007393405966. Eur J Epidemiol. 1997. PMID: 9258525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page